Last reviewed · How we verify
Meriva
At a glance
| Generic name | Meriva |
|---|---|
| Also known as | turmeric, enhanced bioavailability |
| Sponsor | University of Arizona |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | discontinued |
Approved indications
Common side effects
Key clinical trials
- The Effect of Curcumin on Liver Fat Content in Obese Subjects (NA)
- Randomized, Double-Blind, Placebo-Controlled Trial of Meriva® (Curcuminoids) as a Candidate Chemoprevention Agent for Gastric Carcinogenesis (Phase 2)
- Crossover, Multiple Dose Pharmacokinetics of Two Curcumin Formulations in Healthy Volunteers (Phase 1)
- Randomized Window of Opportunity Trial of Anthocyanin Extract and Phospholipid Curcumin in Subjects With Colorectal Adenoma (NA)
- Meriva for Treatment-induced Inflammation and Fatigue in Women With Breast Cancer (Phase 2)
- Assessing the Bioavailability of Leading Phytonutrient Products (NA)
- Effect of Orally Delivered Phytochemicals, Alone, and in Combination, on Aging and Inflammation-Related Effects in the Skin (NA)
- A Prospective Evaluation of the Effect of Curcumin on Dose-limiting Toxicity and Pharmacokinetics of Irinotecan in Colorectal Cancer Patients (Phase 1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |